Clin2
NCT07537855Possibly a fitNot yet recruiting

Xeomin injection with tadalafil for erectile dysfunction

Erectile Dysfunction

Treatments studied

Part of Kidney & urinary, Mental health clinical trials.

This study tests a combination of an injected muscle relaxant (Xeomin) and a common erection pill (tadalafil) to see if it helps men who haven't gotten enough relief from pills alone. It aims to improve erections and sexual satisfaction.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
30 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You must be a man between 18 and 80 years old.
  • You need to have had erectile dysfunction for at least 6 months, confirmed by a doctor.
  • You must be in a monogamous relationship with a female partner for at least 6 months and be comfortable with vaginal sex.
  • You should have tried a PDE5 inhibitor pill (like Viagra or Cialis) and it didn't work well enough.
  • You cannot have certain heart conditions, take nitrates, or have a history of stroke or heart attack in the last 90 days.
  • You cannot have Peyronie's disease ( a curved erection), penile deformity, or a penile implant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07177326Not yet recruiting· Phase 3
Comparing two drug combinations for erectile dysfunction

This study tests two different ways to treat erectile dysfunction (ED): a combination of two commonly used medications (tadalafil and sildenafil) versus a single medication (tadalafil). It aims to see which approach works better and is safe for men with ED.

NCT07642505Recruiting· Phase 4
L-Citrulline and Tadalafil for Mild Erectile Dysfunction

This study tests whether two compounds—L-citrulline (a natural amino acid) and tadalafil (a common erectile dysfunction medication)—work well together for men with mild to moderate erectile problems. The goal is to see if this combination safely improves sexual function.

Banī Suwayf, Beni Suweif Governorate
NCT05955001Recruiting· Phase 2/Phase 3
Tadalafil for early urinary symptoms after prostate surgery

This trial studies whether daily tadalafil (5 mg) can improve early urinary trouble and erection function after endoscopic prostate tissue removal. It may help men whose urinary symptoms continued even after prior medicine.

Al Mansurah, Dakahlia Governorate
NCT07753720Recruiting· Phase 4
Daily tadalafil with or without another treatment for erectile dysfunction

This study tests whether taking tadalafil daily, either alone or with a second treatment, works better for men with erectile dysfunction who have not responded to on-demand pills. It aims to help men who have not had success with current treatments.

Cairo
NCT07319533Not yet recruiting· Phase 2
Exosome injections for moderate to severe erectile dysfunction

This study tests whether exosomes, which are tiny particles that help cells communicate and heal, can improve erectile dysfunction when added to your current treatment. It is for men with moderate to severe erectile dysfunction who haven't had enough help from other options.

Tehran, Tehran Province
NCT06583590Recruiting· Phase 2/Phase 3
Botulinum toxin plus daily tadalafil for erectile dysfunction

This trial tests if combining two treatments—a botulinum toxin injection and a daily oral medication (tadalafil)—can help men with diabetes-related erectile dysfunction who haven't responded well to standard pills. The goal is to see if this combination improves erections better than either treatment alone.

Aswān, Aswan Governorate

Hear when a new Erectile Dysfunction trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.